Ingle JN - Search Results

1

The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cells.

Wu X, Hawse JR, Subramaniam M, Goetz MP, Ingle JN, Spelsberg TC. Wu X, et al. Among authors: ingle jn. Cancer Res. 2009 Mar 1;69(5):1722-7. doi: 10.1158/0008-5472.CAN-08-3933. Epub 2009 Feb 24. Cancer Res. 2009. PMID: 19244106

2

Distinct mechanisms of bisphosphonate action between osteoblasts and breast cancer cells: identity of a potent new bisphosphonate analogue.

Reinholz GG, Getz B, Sanders ES, Karpeisky MY, Padyukova NSh, Mikhailov SN, Ingle JN, Spelsberg TC. Reinholz GG, et al. Among authors: ingle jn. Breast Cancer Res Treat. 2002 Feb;71(3):257-68. doi: 10.1023/a:1014418017382. Breast Cancer Res Treat. 2002. PMID: 12002344

3

Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy.

Witzig TE, Bossy B, Kimlinger T, Roche PC, Ingle JN, Grant C, Donohue J, Suman VJ, Harrington D, Torre-Bueno J, Bauer KD. Witzig TE, et al. Among authors: ingle jn. Clin Cancer Res. 2002 May;8(5):1085-91. Clin Cancer Res. 2002. PMID: 12006523

4

TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors.

Sinclair CS, Adem C, Naderi A, Soderberg CL, Johnson M, Wu K, Wadum L, Couch VL, Sellers TA, Schaid D, Slezak J, Fredericksen Z, Ingle JN, Hartmann L, Jenkins RB, Couch FJ. Sinclair CS, et al. Among authors: ingle jn. Cancer Res. 2002 Jul 1;62(13):3587-91. Cancer Res. 2002. PMID: 12097257

5

Estrogen as therapy for breast cancer.

Ingle JN. Ingle JN. Breast Cancer Res. 2002;4(4):133-6. doi: 10.1186/bcr436. Epub 2002 May 15. Breast Cancer Res. 2002. PMID: 12100736 Free PMC article.

6

Sequencing of hormonal therapy in breast cancer.

Ingle JN. Ingle JN. Breast J. 2002 Nov-Dec;8(6):332-7. doi: 10.1046/j.1524-4741.2002.08602.x. Breast J. 2002. PMID: 12390355 Review.

7

Adjuvant endocrine therapy in postmenopausal breast cancer.

Ingle JN. Ingle JN. Clin Cancer Res. 2003 Jan;9(1 Pt 2):480S-5S. Clin Cancer Res. 2003. PMID: 12538504 Review.

8

Sequencing of endocrine therapy in postmenopausal women with advanced breast cancer.

Ingle JN. Ingle JN. Clin Cancer Res. 2004 Jan 1;10(1 Pt 2):362S-7S. doi: 10.1158/1078-0432.ccr-031200. Clin Cancer Res. 2004. PMID: 14734492

9

Differential gene expression of TGF beta inducible early gene (TIEG), Smad7, Smad2 and Bard1 in normal and malignant breast tissue.

Reinholz MM, An MW, Johnsen SA, Subramaniam M, Suman VJ, Ingle JN, Roche PC, Spelsberg TC. Reinholz MM, et al. Among authors: ingle jn. Breast Cancer Res Treat. 2004 Jul;86(1):75-88. doi: 10.1023/B:BREA.0000032926.74216.7d. Breast Cancer Res Treat. 2004. PMID: 15218362

10

Effects of exemestane and tamoxifen in a postmenopausal breast cancer model.

Jelovac D, Macedo L, Handratta V, Long BJ, Goloubeva OG, Ingle JN, Brodie AM. Jelovac D, et al. Among authors: ingle jn. Clin Cancer Res. 2004 Nov 1;10(21):7375-81. doi: 10.1158/1078-0432.CCR-04-0565. Clin Cancer Res. 2004. PMID: 15534114

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

422 results

Search Page